← Leaderboards
Rajendra S Apte
Washington University
$5,529,164
Attributed
$5,738,851
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $787.5K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,738,851 · 4
By mechanism
R01$3,879,960 · 1
K08$1,020,141 · 1
R21$838,750 · 2
Top collaborators
- Jonathan J Miner2 shared
Most similar at Washington University
Same institution · by research overlap
- James W Harbour$11,773,196
- Kyunghee Choi$18,130,511
- Matthew J. Silva$20,876,359
- Gwendalyn J Randolph$35,563,954
- Anne Mary Bowcock$15,823,763
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessPlayAge Related Macular DegenerationMacrophageFunctional DisorderChoroidal NeovascularizationPhenotypeAffectAge RelatedImmune SystemExudative Age-Related Macular DegenerationIn VivoIn VitroOcular NeovascularizationCellsPathway InteractionsImmuneDiabetic RetinopathyCell ProliferationBlood VesselsAngiogenesisInflammationGene ExpressionPrevent
Grant awards (22)
Macrophage miR146B and Ocular Neovascularization$394,157
R01 · FY2021 · EY · contact PI
MACROPHAGE MIR146B AND OCULAR NEOVASCULARIZATION$393,386
R01 · FY2021 · EY · contact PI
Macrophage miR146B and Ocular Neovascularization$406,348
R01 · FY2020 · EY · contact PI
Macrophage miR146B and Ocular Neovascularization$405,273
R01 · FY2019 · EY · contact PI
Macrophage miR146B and Ocular Neovascularization$401,833
R01 · FY2018 · EY · contact PI
PATHOGENESIS OF OCULAR ZIKA VIRUS INFECTION$190,625
R21 · FY2018 · EY
FGF SIGNALING IN OCULAR NEOVASCULARIZATION$228,750
R21 · FY2017 · EY · contact PI
PATHOGENESIS OF OCULAR ZIKA VIRUS INFECTION$228,750
R21 · FY2017 · EY
FGF SIGNALING IN OCULAR NEOVASCULARIZATION$190,625
R21 · FY2016 · EY · contact PI
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE$321,753
R01 · FY2014 · EY · contact PI
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE$311,904
R01 · FY2013 · EY · contact PI
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE$122,250
R01 · FY2013 · EY · contact PI
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE$328,320
R01 · FY2012 · EY · contact PI
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE$328,320
R01 · FY2011 · EY · contact PI
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE$124,416
R01 · FY2011 · EY · contact PI
THE IMPORTANCE OF MACROPHAGE SENESCENCE IN REGULATING ANGIOGENESIS IN THE EYE$342,000
R01 · FY2010 · EY · contact PI
Immune Mechanisms in Choroidal Neovascularization$204,851
K08 · FY2009 · EY · contact PI
Immune Mechanisms in Choroidal Neovascularization$52,984
K08 · FY2009 · EY · contact PI
Immune Mechanisms in Choroidal Neovascularization$199,669
K08 · FY2008 · EY · contact PI
Immune Mechanisms in Choroidal Neovascularization$194,641
K08 · FY2007 · EY · contact PI
Immune Mechanisms in Choroidal Neovascularization$189,758
K08 · FY2006 · EY · contact PI
Immune Mechanisms in Choroidal Neovascularization$178,238
K08 · FY2005 · EY